Home / Inspections / 861829

FDA Inspection 861829 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3002807751

The FDA completed an inspection of Novo Nordisk A/S on May 10, 2013 in Kalundborg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 10, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Kalundborg (Denmark)

Facility

Other inspections at this facility

  • 1326428 (VAI Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1209127 (VAI Thu May 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1230597 (VAI Fri Dec 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1107225 (NAI Fri Sep 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1028554 (NAI Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources